David E Morris

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative
    David E Morris
    Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC 27514, USA
    Int J Radiat Oncol Biol Phys 62:3-19. 2005
  2. ncbi request reprint CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience
    Maria G Matheus
    Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    AJNR Am J Neuroradiol 25:1211-7. 2004
  3. doi request reprint Current status of postoperative radiation for non-small-cell lung cancer
    Mert Saynak
    Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Semin Radiat Oncol 20:192-200. 2010
  4. ncbi request reprint Current and evolving treatment options for limited stage small cell lung cancer
    Carrie B Lee
    Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, 27599, USA
    Curr Opin Oncol 18:162-72. 2006
  5. ncbi request reprint Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer
    Lester Kwock
    Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
    Lancet Oncol 7:859-68. 2006
  6. doi request reprint Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small ce
    Thomas E Stinchcombe
    Multidisciplinary Thoracic Oncology Program, 3009 Old Clinic Building CB 7305, Chapel Hill, NC 27599 7305, USA
    J Thorac Oncol 3:250-7. 2008
  7. ncbi request reprint Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy
    Matthew G Ewend
    Division of Neurosurgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    J Natl Compr Canc Netw 6:505-13; quiz 514. 2008
  8. doi request reprint Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer
    Carrie B Lee
    Division of Hematology Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill, North Carolina, USA
    J Thorac Oncol 4:74-9. 2009
  9. doi request reprint Normal tissue tolerance for high-grade gliomas: is it an issue?
    David E Morris
    Department of Radiation Oncology, UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA
    Semin Radiat Oncol 19:187-92. 2009
  10. doi request reprint Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
    Randall J Kimple
    Departments of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
    Am J Clin Oncol 33:265-70. 2010

Detail Information

Publications21

  1. ncbi request reprint Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative
    David E Morris
    Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC 27514, USA
    Int J Radiat Oncol Biol Phys 62:3-19. 2005
    ....
  2. ncbi request reprint CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience
    Maria G Matheus
    Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    AJNR Am J Neuroradiol 25:1211-7. 2004
    ..The GliaSite system delivers local, high radiation after brain tumor resection. We describe the imaging appearance of the device and the changes it causes...
  3. doi request reprint Current status of postoperative radiation for non-small-cell lung cancer
    Mert Saynak
    Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Semin Radiat Oncol 20:192-200. 2010
    ..Therefore, a reassessment of the utility of postoperative radiation therapy using limited fields and modern techniques is warranted...
  4. ncbi request reprint Current and evolving treatment options for limited stage small cell lung cancer
    Carrie B Lee
    Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, 27599, USA
    Curr Opin Oncol 18:162-72. 2006
    ..Several targeted agents have also been evaluated. This review will highlight the data that have greatly impacted on the standard of limited stage small cell lung cancer care...
  5. ncbi request reprint Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer
    Lester Kwock
    Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
    Lancet Oncol 7:859-68. 2006
    ....
  6. doi request reprint Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small ce
    Thomas E Stinchcombe
    Multidisciplinary Thoracic Oncology Program, 3009 Old Clinic Building CB 7305, Chapel Hill, NC 27599 7305, USA
    J Thorac Oncol 3:250-7. 2008
    ..We investigate the tolerability of gefitinib in combined modality therapy in combination with three-dimensional thoracic conformal radiation therapy (3-dimensional TCRT)...
  7. ncbi request reprint Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy
    Matthew G Ewend
    Division of Neurosurgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    J Natl Compr Canc Netw 6:505-13; quiz 514. 2008
    ....
  8. doi request reprint Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer
    Carrie B Lee
    Division of Hematology Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill, North Carolina, USA
    J Thorac Oncol 4:74-9. 2009
    ..Dose escalation of radiotherapy is one strategy used to improve locoregional control and survival, but it increases the risk of both early and late treatment related toxicities...
  9. doi request reprint Normal tissue tolerance for high-grade gliomas: is it an issue?
    David E Morris
    Department of Radiation Oncology, UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA
    Semin Radiat Oncol 19:187-92. 2009
    ....
  10. doi request reprint Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
    Randall J Kimple
    Departments of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
    Am J Clin Oncol 33:265-70. 2010
    ..We began this study to describe our results and toxicities in the over 70 population treated with concurrent temozolomide and radiation for GBM, and to describe our outcomes treating elderly patients with GBM regardless of therapy...
  11. ncbi request reprint Combined modality therapy for stage III non-small cell lung cancer
    Thomas E Stinchcombe
    Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599 7305, USA
    Oncologist 11:809-23. 2006
    ..Thus, continued development and participation in clinical trials is crucial to further improvements in the treatment of patients with stage III disease...
  12. ncbi request reprint Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy
    Thomas E Stinchcombe
    Department of Hematology Oncology, University of North Carolina, Chapel Hill NC 27599 7305, USA
    Lung Cancer 52:67-74. 2006
    ..To evaluate the influence of clinical covariates, particularly pre-chemotherapy gross tumor volume (GTV), post-chemotherapy GTV, on overall survival in the treatment of stage III non-small cell lung cancer (NSCLC)...
  13. ncbi request reprint The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy
    Mark A Socinski
    The Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599 7305, USA
    Semin Oncol 33:S32-8. 2006
    ....
  14. ncbi request reprint Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
    Daniel B Fried
    Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Clin Oncol 22:4837-45. 2004
    ..In addition, we assessed the impact of radiation fractionation and chemotherapeutic regimen on timing...
  15. ncbi request reprint Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer
    Frank C Detterbeck
    Division of Cardiothoracic Surgery, Medical School Wing C Room 354, CB 7065, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7065, USA
    Chest 126:1656-66. 2004
    ..Further technologic improvements in PET scanners are likely to bring further benefits to the management of patients with lung cancer in the future...
  16. ncbi request reprint Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial
    Mark A Socinski
    Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, CB 7305, Chapel Hill, NC 27599 7305, USA
    J Clin Oncol 22:4341-50. 2004
    ..Dose escalation using three-dimensional thoracic conformal radiation therapy (TCRT) is one strategy to improve local control and perhaps survival...
  17. ncbi request reprint Chemotherapeutic management of stage IV non-small cell lung cancer
    Mark A Socinski
    Multidisciplinary Thoracic Oncology Program, CB 7305, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
    Chest 123:226S-243S. 2003
    ..In addition, this awareness will allow them to make referrals, when appropriate, to physicians who are trained in the administration of chemotherapy and the management of patients undergoing such therapy...
  18. ncbi request reprint High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial
    Julian G Rosenman
    Department of Radiation Oncology, Lineberger Comprehensive Cancer Center of the University of North Carolina University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
    Int J Radiat Oncol Biol Phys 54:348-56. 2002
    ..The median survival of 24 months, 3-year survival rate of 38%, and the high dose of radiation used justified a critical analysis of the technical and clinical components of this trial...
  19. ncbi request reprint The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma
    May N Tsao
    The American Society for Therapeutic Radiology and Oncology, Fairfax, VA 22033, USA
    Int J Radiat Oncol Biol Phys 63:47-55. 2005
    ..To systematically review the evidence for the use of stereotactic radiosurgery or stereotactic fractionated radiation therapy in adult patients with malignant glioma...
  20. ncbi request reprint The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases
    Minesh P Mehta
    The American Society for Therapeutic Radiology and Oncology, Fairfax, VA 22033, USA
    Int J Radiat Oncol Biol Phys 63:37-46. 2005
    ..To systematically review the evidence for the use of stereotactic radiosurgery in adult patients with brain metastases...
  21. ncbi request reprint Cyst degeneration in craniofacial fibrous dysplasia: clinical presentation and management
    Enrina Diah
    Craniofacial Center and Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
    J Neurosurg 107:504-8. 2007
    ..Because existing reports of this entity are limited, the object of this study was to describe the presentation and management of cyst degeneration in a relatively large series of patients...